Showing:
NANS
|
All Dates
(2 posts)
Articles
Humana Imposes Further Restrictions on Medicare Coverage for Neuromodulation Therapies
Open enrollment for Medicare Advantage runs October 15 – December 7. Physicians should be aware that Humana’s Medicare Advantage plan has some of the most rigorous and strict prior authorization requirements for neuromodulation therapies like spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS).
Read More ->
NANS, along with 11 medical societies, presses Humana on coverage for closed-loop SCS
Humana, Evicore, Cigna, and UPMC all had policies that characterized closed-loop SCS as “experimental, investigational and/or unproven.” NANS led efforts with the MPW to issue a letter to Humana, urging them to revise their policy.
Read More ->